BURLINGAME, Calif.--(BUSINESS WIRE)--Urigen N.A., Inc., a specialty pharmaceutical company focused on the development of treatments for urological disorders, announced the resignation of Benson Fong from Urigen’s Board of Directors, effective June 14, 2007. Mr. Fong resigned amicably from Urigen’s Board of Directors in order to pursue other business and personal opportunities.
